Search

everythinglearnresearchcommunity

for

Search:↓

FERONIA and LRX proteins help control cell growth in plants by regulating vacuole expansion.

rwSALT provides precise hair regrowth measurement from scalp photos.

Ritlecitinib effectively treats alopecia areata in patients 12 and older with fewer side effects.

Fluid Platelet-Rich Fibrin (PRF) is more effective and faster at improving acne scars than Platelet-Rich Plasma (PRP), with similar mild side effects.

FLRG and follistatin have different roles in wound healing.

Ritlecitinib is being tested for safety and effectiveness in young children with severe alopecia areata.

Tofacitinib is effective and safe for elderly patients with ulcerative colitis.

A-PRF+ improves bone healing and stability in oral surgery.

Tofacitinib helped regrow hair in a lupus patient with alopecia.

Tofacitinib effectively promotes hair regrowth in alopecia areata with minimal side effects.

Combining Ficlatuzumab and Gefitinib can cause severe hair loss.

Fluconazole-loaded hair gel may offer a longer-lasting dandruff treatment.

Tofacitinib effectively regrows hair in alopecia areata patients, especially in younger individuals, with manageable side effects.

Many drugs can cause lipid metabolism issues, and labels need better warnings.

Radiofrequency treatment helps rejuvenate skin by boosting collagen and blood vessel growth.

BcFLA1 protein is crucial for root hair growth in response to low phosphate in Brassica carinata.

The study found that the hair loss condition in Cesky Fousek dogs is influenced by multiple genes affecting skin and muscle structure, fat metabolism, and immunity.

The new assay can help develop products for hair re-growth.

Tofacitinib helped regrow hair in most adolescents with alopecia areata, but more research is needed.

Alitretinoin can effectively treat frontal fibrosing alopecia.

Taking oral isotretinoin with creams worked better for treating a type of hair loss than creams alone.

A rare skin condition usually found near the eyes was found on a farmer's scalp.

Scientists made a carbon-14 labeled version of a drug with a 48% yield and over 99% purity.

The FDA approved Litfulo® for treating severe alopecia areata in people aged 12 and older.

Alternative treatments are needed when Tofacitinib alone fails for alopecia areata.

The new ddPCR method reliably detects unwanted viruses in CAR-T cell products, ensuring their safety for patients.

Ritlecitinib is generally safe for long-term use, with mostly mild side effects.

PRF lysates reduce inflammation in cancer cells and boost immune response in healthy oral cells.

Tofacitinib effectively treated a woman's severe symptoms from a rare autoimmune condition.